CPEB4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.532400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.588800E-01
Normal-vs-Stage2
4.900000E-01
Normal-vs-Stage3
1.392390E-01
Normal-vs-Stage4
8.809800E-01
Stage1-vs-Stage2
1.544040E-01
Stage1-vs-Stage3
3.193800E-02
Stage1-vs-Stage4
6.114200E-01
Stage2-vs-Stage3
2.332400E-01
Stage2-vs-Stage4
5.881400E-01
Stage3-vs-Stage4
2.137800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.373800E-01
Normal-vs-AfricanAmerican
8.611800E-01
Normal-vs-Asian
4.132000E-01
Caucasian-vs-AfricanAmerican
3.107400E-01
Caucasian-vs-Asian
5.613000E-01
AfricanAmerican-vs-Asian
2.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.613200E-01
Normal-vs-Female
6.647000E-01
Male-vs-Female
9.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.437800E-01
Normal-vs-Age(41-60Yrs)
9.408200E-01
Normal-vs-Age(61-80Yrs)
5.231000E-01
Normal-vs-Age(81-100Yrs)
1.133600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.268800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.119800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.495600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.382050E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.016450E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.466550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.118000E-01
Normal-vs-Daily Drinker
3.582000E-01
Normal-vs-Weekly Drinker
1.765800E-01
Normal-vs-Occasional Drinker
8.379200E-01
Normal-vs-Social Drinker
9.942200E-01
Non Drinker-vs-Daily Drinker
8.508600E-01
Non Drinker-vs-Weekly Drinker
6.643600E-01
Non Drinker-vs-Occasional Drinker
8.233900E-02
Non Drinker-vs-Social Drinker
2.183600E-01
Daily Drinker-vs-Weekly Drinker
8.362800E-01
Daily Drinker-vs-Occasional Drinker
6.565800E-02
Daily Drinker-vs-Social Drinker
1.683190E-01
Weekly Drinker-vs-Occasional Drinker
5.161700E-02
Weekly Drinker-vs-Social Drinker
1.454630E-01
Occasional Drinker-vs-Social Drinker
7.078600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.475250E-01
Normal-vs-Grade 2
1.765920E-02
Normal-vs-Grade 3
3.085700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.580570E-01
Grade 1-vs-Grade 3
1.563440E-01
Grade 1-vs-Grade 4
1.475250E-01
Grade 2-vs-Grade 3
8.950400E-01
Grade 2-vs-Grade 4
1.765920E-02
Grade 3-vs-Grade 4
3.085700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.000600E-01
Normal-vs-NonDiabetic
6.399000E-01
Diabetic-vs-NonDiabetic
4.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.324200E-01
Normal-vs-NoPancreatitis
6.297800E-01
Pancreatitis-vs-NoPancreatitis
3.087800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.133000E-01
Normal-vs-N1
5.221000E-01
N0-vs-N1
5.227200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.137000E-01
Normal-vs-TP53-NonMutant
9.800600E-01
TP53-Mutant-vs-TP53-NonMutant
3.077800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
